It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Nauseef JT, Sun MP, Thomas C, et al. A phase I/II dose-escalation study of fractionated 225Ac-J591 for progressive metastatic castration-resistant prostate cancer in patients with prior treatment with ...